Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study.
about
Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsAntibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipientsAntibody induction versus corticosteroid induction for liver transplant recipientsImmunosuppressive T cell antibody induction therapy for liver transplant recipientsNew directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation.Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantationTacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.Induction immunosuppression in liver transplantation: a review.Lymphodepletional strategies in transplantation.Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.Antithymocyte Globulin Induction Therapy in Liver Transplant: Old Drug, New Uses.Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy.Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction
P2860
Q24194087-88538272-3A8C-4C9D-AD4D-95DE2E4D4374Q24194518-B283D218-43CA-4181-A2BE-4A1A00CD28C6Q24197745-2EFECF2A-69EF-4731-88AD-A8866D615A81Q24197859-5A4E3E36-42F9-451E-A582-12621D82C018Q24235428-0AFE7A98-D510-4691-8472-C1D57CE67AAFQ26823090-556B3845-AF25-46B0-9F84-47AD8D2793C0Q34093895-0BAAFF30-0323-4BFD-8ABD-8698EE1DB96AQ36501716-FC84033E-169A-4D57-AA3E-B7AD11277F9BQ38019054-7415BC15-4652-4895-95B8-B2ECAB3B482FQ38104751-15376503-0EFF-461D-88F8-3A95FD380C42Q38118743-4D5E2AD4-FD33-4C34-917B-87159051C9D8Q38682284-59FFDBD9-DBA3-4296-A397-1A73A25AF41CQ38737314-254A37F7-252B-48E8-9790-E45905AEA03AQ38826263-0AECDCE3-2CEE-43DF-A62E-CEE8D3537BE9Q41627118-15834E81-B9CA-495E-ABD1-503F1FC0E75CQ58773059-817FA8E0-D545-4621-8B4B-72720DD795DA
P2860
Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Thymoglobulin induction in liv ...... randomized prospective study.
@en
Thymoglobulin induction in liv ...... randomized prospective study.
@nl
type
label
Thymoglobulin induction in liv ...... randomized prospective study.
@en
Thymoglobulin induction in liv ...... randomized prospective study.
@nl
prefLabel
Thymoglobulin induction in liv ...... randomized prospective study.
@en
Thymoglobulin induction in liv ...... randomized prospective study.
@nl
P2093
P356
P1476
Thymoglobulin induction in liv ...... randomized prospective study.
@en
P2093
Belhassen Seket
Catherine Boucaud
Gabriella Pittau
Jérôme Dumortier
Olivier Boillot
Yves Bouffard
P304
P356
10.1002/LT.21905
P577
2009-11-01T00:00:00Z